NCT05853042View on ClinicalTrials.gov

MERITnI - Mindray-hs-cTnI Assay: Analytical and Clinical Evaluation for the Diagnosis and RIsk AssessmenT of Myocardial InfarctIon.

Active, not recruitingOBSERVATIONAL
Enrollment

1,500

Participants

Timeline

Start Date

December 12, 2022

Primary Completion Date

March 15, 2025

Study Completion Date

May 15, 2025

Conditions
Acute Myocardial InfarctionAcute Coronary Syndrome
Interventions
DIAGNOSTIC_TEST

high-sensitivity cardiac troponin testing

Lithium heparin plasma samples will be measured with Mindray Bio-Medical CL-1200i Chemiluminescence Immunoassay Analyzer.

Trial Locations (1)

55404

Hennepin Healthcare Research Institute / Hennepin County Medical Center, Minneapolis

Sponsors
All Listed Sponsors
collaborator

Mindray Bio-Medical Electronics Co., Ltd.

UNKNOWN

lead

Hennepin Healthcare Research Institute

OTHER